[A case of gastric cancer with bilateral ovarian metastasis after gastrectomy performed ovarian resection]

Gan To Kagaku Ryoho. 2010 Nov;37(12):2490-2.
[Article in Japanese]

Abstract

The patient was a 51-year-old female, who underwent radical surgery for cancer of remnant stomach in May 2006 (f-T4N0M0P0H0CY0, por 2, Stage IIIA, Cur B). Bilateral ovarian resection was performed in March 2009 for bilateral ovarian metastasis, so called "Krukenberg tumor" with peritoneal dissemination detected with CT scan after one-year adjuvant chemotherapy with S-1 (80 mg/m2, 4 weeks on and 2 weeks off). As of June 2010, she is alive and maintain her status quo after 6 courses of S-1 plus CDDP combination therapy (S-1 80 mg/m2, 3 weeks on, CDDP 60 mg/m2, started at day 8, ended 35 days later) followed by S-1 for residual peritoneal dissemination detected at operation. In ovary metastasis of gastric cancer, even if accompanied by peritoneum metastasis, ovarian resection as a reduction surgery followed by chemotherapy may improve survival.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Antimetabolites, Antineoplastic / administration & dosage
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cisplatin / administration & dosage
  • Combined Modality Therapy
  • Drug Combinations
  • Female
  • Gastrectomy
  • Humans
  • Krukenberg Tumor / secondary*
  • Krukenberg Tumor / therapy*
  • Middle Aged
  • Ovarian Neoplasms / secondary*
  • Ovarian Neoplasms / therapy*
  • Ovariectomy
  • Oxonic Acid / administration & dosage
  • Stomach Neoplasms / pathology*
  • Stomach Neoplasms / surgery*
  • Tegafur / administration & dosage

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Drug Combinations
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid
  • Cisplatin